LABORATORY RESEARCH Trefoil Factor 1 Acts to Suppress Senescence Induced by Oncogene Activation During the Cellular Transformation Process Researchers report that trefoil factor 1 acts as a promoter of tumorigenesis in the context of prostate and pancreatic cancers by suppressing oncogene-induced senescence. [Proc Natl Acad Sci U S A] Targeted Identification of Metastasis-Associated Cell-Surface Sialoglycoproteins in Prostate Cancer Researchers have combined glycan metabolic labeling with mass spectrometry analysis to identify and characterize metastasis-associated cell surface sialoglycoproteins. [Mol Cell Proteomics] Cancer Associated Fibroblasts Exploit Reactive Oxygen Species Through a Proinflammatory Signature Leading to Epithelial Mesenchymal Transition and Stemness Researchers demonstrate that cancer associated fibroblasts induce epithelial mesenchymal transition and stemness through a proinflammatory signature, which exploits reactive oxygen species to drive a migratory and aggressive phenotype of prostate carcinoma cells. [Antioxid Redox Signal] Diagnosis of Prostate Cancer Using Differentially Expressed Genes in Stroma Results indicate that the prostate cancer microenvironment exhibits reproducible changes useful for categorizing the presence of tumor in patients when a prostate sample is derived from near the tumor but does not contain any recognizable tumor. [Cancer Res] Role for Stromal Heterogeneity in Prostate Tumorigenesis To test the hypothesis that prostate cancer progression is dependent on the heterogeneous TGF-ß responsive microenvironment, a tissue recombination experiment was designed where the ratio of TGF-ß responsive and nonresponsive stromal cells were varied. [Cancer Res] Endoglin Regulates Cancer-Stromal Cell Interactions in Prostate Tumors Results firmly establish the pathophysiological involvement of endoglin in prostate cancer progression, and they show how endoglin acts to support the viability of tumor infiltrating carcinoma-associated fibroblasts in the tumor microenvironment to promote neovascularization and growth. [Cancer Res] Alterations in Nucleolar Structure and Gene Expression Programs in Prostatic Neoplasia Are Driven by the MYC Oncogene These studies demonstrate that overexpression of the MYC oncogene increases nucleolar number and size and a nucleolar program of gene expression in prostate epithelial cells, thus providing a molecular mechanism responsible for hallmark nucleolar alterations in prostatic neoplasia. [Am J Pathol] Downregulation of ZNF132 in Prostate Cancer Is Associated with Aberrant Promoter Hypermethylation and Poor Prognosis Results show that downregulation of ZNF132 is associated with aggressive prostate cancer (PC) and furthermore identify ZNF132 as a new candidate methylation marker for PC. [Int J Cancer] Modulation of the Tumor Cell Death Pathway by Androgen Receptor in Response to Cytotoxic Stimuli Results provide compelling evidence for involvement of androgen receptor (AR) in deciding types of tumor cell death upon cytotoxic stimuli, and specifically, blockade of AR activities could change necrosis to apoptosis in tumor cells. [J Cell Physiol] PI3 Kinase Inhibition on TRAIL-Induced Apoptosis Correlates with Androgen-Sensitivity and p21 Expression in Prostate Cancer Cells Results suggest that TNF-related apoptosis-inducing ligand (TRAIL) resistance is not regulated simply by a PI3-kinase/AKT survival pathway associated with inactivating PTEN mutations but may also be modulated by downstream androgen receptor responsive targets such as p21. [Apoptosis] Polymorphisms of ADIPOQ and ADIPOR1 and Prostate Cancer Risk Researchers studied the association of prostate cancer risk with haplotype tagging single nucleotide polymorphisms of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) chosen based on their functional relevance or association with other types of cancer. [Metabolism] CLINICAL RESEARCH Short-Term Neoadjuvant Androgen Deprivation and Radiotherapy for Locally Advanced Prostate Cancer: 10-Year Data from the TROG 96.01 Randomized Trial Six months of neoadjuvant androgen deprivation combined radiotherapy is an effective treatment option for locally advanced prostate cancer, particularly in men without nodal metastases or pre-existing metabolic comorbidities that could be exacerbated by prolonged androgen deprivation. [Lancet Oncol] Randomized Prostate Cancer Screening Trial: 20 Year Follow-Up After 20 years of follow-up the rate of death from prostate cancer did not differ significantly between men in the screening group and those in the control group. [BMJ] The Androgen-Regulated Calcium-Activated Nucleotidase 1 (CANT1) Is Commonly Overexpressed in Prostate Cancer and Is Tumor-Biologically Relevant In Vitro CANT1 is commonly overexpressed in the vast majority of primary prostate carcinomas and in the precursor lesion prostatic intraepithelial neoplasia and may represent a novel prognostic biomarker. [Am J Pathol] |